Loading...
•
Dec 31, 2021
Astrana Health Q4 2021 Earnings Report
Announced fourth quarter and year-end results, demonstrating growth in revenue and net income.
Key Takeaways
Apollo Medical Holdings reported a 10% increase in total revenue to $195.1 million and a 37% increase in net income to $13.8 million for the fourth quarter of 2021. The company's EPS - diluted increased by 11% to $0.30 per share.
Total revenue increased by 10% year-over-year to $195.1 million.
Net income attributable to ApolloMed increased by 37% year-over-year to $13.8 million.
Earnings per share - diluted increased by 11% year-over-year to $0.30.
Acquisition of Jade Health expected to close by the end of the second quarter of 2022.
Revenue by Segment
Forward Guidance
ApolloMed anticipates full-year 2022 total revenue of between $1.03 billion and $1.08 billion, based on the Company’s existing business, current view of existing market conditions, and assumptions for the year ending December 31, 2022.
Positive Outlook
- Strong organic growth in core markets.
- Participation in a Centers for Medicare & Medicaid Services Innovation Center (CMMI) innovation model.
- Working closely with the Jade Health team and are on target to close by the end of the 2022 second quarter.
- M&A pipeline remains robust.
- Newly formed business development team in place.
Challenges Ahead
- Uncertainties related to its participation in a Centers for Medicare & Medicaid Services Innovation Center (“CMMI”) innovation model.
- Ongoing investment in staff to support future growth.
- Certain investments that depend on unpredictable macroeconomic factors.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...